In Vitro Diagnostics Market Research Reports & Industry Analysis

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... Heparin testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the Heparin testing market ... as well as 5-year test volume forecasts by country and market segment. The report examines market applications of chromogenic substrates, ...

... Fibrinogen testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the Fibrinogen testing market ... well as 5-year test volume forecasts by country and market segment. The report examines market applications of chromogenic ...

... malignancy assays and the rapid market expansion worldwide.This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany ... test volume and sales forecasts by country and market segment.The report also examines market applications of DNA probes, biochips/microarrays, monoclonal ...

... technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ... report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ...

... overview of the laboratory and POC coagulation testing markets, including estimates of facilities performing coagulation tests, test volume and sales forecasts for coagulation reagents and ... test volume estimates for 38 coagulation assays.The report also presents strategic profiles of current and emerging suppliers of coagulation products in terms of their ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... /Private LaboratoriesCurrent and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests.- Review of current instrumentation technologies, and feature ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... /Group PracticesCurrent and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests.- Review of current instrumentation technologies, and feature ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests.- Review of current instrumentation technologies, and feature ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

... ambulatory care centers, including controls, calibrators and consumables.RationaleThe clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

... ambulatory care centers, including controls, calibrators and consumables.RationaleThe clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... /Group PracticesCurrent and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

... coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation ... characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Antidepressants. Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison ...

... Analysis Sales and market share estimates for leading suppliers of clinical chemistry and immunodiagnostic products by country and individual product. Geographic Regions ... Centers Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature ...

... assessment of Ceva's technological know-how, marketing tactics and strategic directions in the global animal health market.Technological Know-How- Internally developed and acquired animal health technologies, processes and related capabilities.- Proprietary technologies and ...

... assessment of Merck's technological know-how, marketing tactics and strategic directions in the global animal health market.Technological Know-How- Internally developed and acquired animal health technologies, processes and related capabilities.- Proprietary technologies and ...

... unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Abbott and its main competitors, as well as a profile of the companys diagnostics business ...

... the next ten years.Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin ... over 40 blood banking tests, including NAT, by market segment: - Blood Centers- Plasma Fractionation Facilities- Hospitals- Commercial/Private Laboratories- Military Blood BanksCurrent and ...

... for further automating molecular diagnostic methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the ... probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio ...

This report reviews operating characteristics and features of 50 high-, medium-, and low-volume/POC clinical chemistry and immunodiagnostic systems. Contains 33 pages

This report reviews major analyzers used for microbiology testing, including their operating characteristics, features and selling prices. Contains 20 pages

The report identifies the major opportunities for hematology and flow cytometry instruments, consumables, and auxiliary products; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers. Contains 23 pages

This 42-page report provides detailed analyses of current and emerging hematology and flow cytometry technologies, and their potential market applications ...

... assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for hemostasis testing.The report also includes strategic assessments of current and emerging suppliers of hemostasis products, including marketing tactics, technological know-how ...

... report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips ... report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales ...

... detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays ... strategic assessments of current and emerging suppliers ofmolecular diagnosticsproducts, including their sales, product portfolios, marketing tactics, technological know-how, new products ...

This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA ... other.The report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing ...

... , autologous blood transfusion/freezing and their potential applications for transfusion diagnostic.The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological ...

... analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI ... spectroscopy. The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution ...

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key trends in ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ...

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300.VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key German market trends; ...

Complete report $8,800. DataPack (test volumes, sales forecasts, supplier shares) $5,700.VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key Japanese market trends; ...

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300.VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key Spanish market trends; ...

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key UK market trends; reviews ...

Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews ...

... UK endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.The report provides test ... Ab, TPO Ab and TSH.During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ...

... laboratories closer to the patient. Market Segmentation Analysis Review of the physician office/group practice diagnostics market, including its dynamics, trends, structure ... prices. Technology Review Emerging technologies and their applications for physician office/group practice diagnostic testing Comprehensive listings of companies developing or marketing ...

... from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive ...

... are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of the 10 major POC market segments ... ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers and by test category: Routine and Special ...

... VPGMarketResearch contains 31 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...